Bioactive constituents of Chinese natural medicines. VII.1 Inhibitors of degranulation in RBL-2H3 cells and absolute stereostructures of three new diarylheptanoid glycosides from the bark of Myrica rubra

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 2, 2002, Pages 208-215

  Matsuda, Hisashi ^a   Morikawa, Toshio ^a   Tao, Jing ^a   Ueda, Kazuho ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

(+) S myricanol 5 O D glucopyranoside; Degranulation inhibitor; Myrica rubra; Myricanene A 5 O L arabinofuranosyl(1 6) D glucopyranoside; RBL 2H3 cell

Indexed keywords

3,5 DIMETHOXY 4 HYDROXYPHENOL 1 O BETA DEXTRO (6' O GALLOYL)GLUCOPYRANODIE; ACETYLURSOLIC ACID; ALPHITOLIC ACID; BETA N ACETYLHEXOSAMINIDASE; CURCUMIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOL DERIVATIVE; GALLIC ACID; GLYCOSIDE; HEPTANE DERIVATIVE; MASLINIC ACID; MYRICADIOL; MYRICANENE A; MYRICANENE A 5 O ALPHA LEVO ARABINOFURANOSYL(1-6) BETA DEXTRO GLUCOPYRANOSIDE; MYRICANENE B; MYRICANENE B 5 O ALPHA LEVO ARABINOFURANOSYL(1-6) BETA DEXTRO GLUCOPYRANOSIDE; MYRICANOL; MYRICANOL 5 O BETA DEXTRO GLUCOPYRANOSIDE; MYRICANOL GLUCOSIDE; MYRICANONE; MYRICETIN; MYRICETIN 3 RHAMNOSIDE; QUERCITRIN; RHOIPTELENOL; SITOSTEROL; TARAXEROL; UNCLASSIFIED DRUG; URSOLIC ACID; URSOLIC ACID DERIVATIVE; URSONIC ACID; ENZYME INHIBITOR;

ANIMAL CELL; ARTICLE; BARK; BASOPHIL DEGRANULATION; CHEMICAL STRUCTURE; CHINESE MEDICINE; CONTROLLED STUDY; MEDICINAL PLANT; MYRICA RUBRA; NONHUMAN; PHYSICAL CHEMISTRY; RAT; ANIMAL; CELL CULTURE; CHEMISTRY; CONFORMATION; DEGRANULATION; DRUG ANTAGONISM; DRUG EFFECT; ISOLATION AND PURIFICATION; MAST CELL LEUKEMIA; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; CELL DEGRANULATION; ENZYME INHIBITORS; GLYCOSIDES; LEUKEMIA, BASOPHILIC, ACUTE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; RATS; TUMOR CELLS, CULTURED;

EID: 0036479575     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.208     Document Type: Article

References (61)

1. Part VI: Matsuda H., Ohta T., Kawaguchi A., Yoshikawa M., Chem. Pharm. Bull., 49, 69-72 (2001).
2. Nonaka G., Muta M., Nishioka I., Phytochemistry, 22, 237-241 (1983).
3. Sakurai N., Yaguchi Y., Inoue T., Phytochemistry, 26, 217-219 (1987).
4. Inoue T., Arai Y., Nagai M., Yakugaku Zasshi, 104, 37-41 (1984).
5. Takeda Y., Fujita T., Shingu T., Ogimi C., Chem. Pharm. Bull., 35, 2569-2573 (1987).
6. Yaguchi Y., Sakurai N., Nagai M., Inoue T., Chem. Pharm. Bull., 36, 1419-1424 (1988).
7. Sakurai N., Yaguchi Y., Hirakawa T., Nagai M., Inoue T., Phytochemistry, 30, 3077-3079 (1991).
8. Inoue T., Yakugaku Zasshi, 113, 181-197 (1993).
9. Ohta S., Sakurai N., Kamogawa A., Yaguchi Y., Inoue T., Shinoda M., Yakugaku Zasshi, 112, 244-252 (1992).
10. Matsuda H., Higashino M., Chen W., Tosa H., Iinuma M., Kubo M., Biol. Pharm. Bull., 18, 1148-1150 (1995).
11. Matsuda H., Yamazaki M., Matsuo K., Asanuma Y., Kubo M., Biol. Pharm. Bull., 24, 259-263 (2001).
12. a) Matsuda H., Kageura T., Morikawa T., Toguchida I., Harima S., Yoshikawa M., Bioorg. Med. Chem. Lett., 10, 323-327 (2000);
13. b) Yoshikawa M., Morikawa T., Toguchida I., Harima S., Matsuda H., Chem. Pharm. Bull., 48, 651-656 (2000);
14. c) Matsuda H., Kageura T., Inoue Y., Morikawa T., Yoshikawa M., Tetrahedron, 56, 7763-7777 (2000);
15. d) Matsuda H., Morikawa T., Toguchida I., Park J.-Y., Harima S., Yoshikawa M., Bioorg. Med. Chem., 9, 41-50 (2001);
16. e) Matsuda H., Morikawa T., Ninomiya K., Yoshikawa M., Bioorg. Med. Chem., ibid., 9, 909-916 (2001);
17. f) Matsuda H., Kageura T., Oda M., Morikawa T., Sakamoto Y., Yoshikawa M., Chem. Pharm. Bull., 49, 716-720 (2001);
18. g) Murakami T., Kishi A., Sakurama T., Matsuda H., Yoshikawa M., Heterocycles, 54, 957-966 (2001);
19. h) Matsuda H., Morikawa T., Toguchida I., Ninomiya K., Yoshikawa M., Heterocycles, ibid., 55, 841-846 (2001);
20. i) Kimura I., Yoshikawa M., Kobayashi S., Sugihara Y., Suzuki M., Oominami H., Murakami T., Matsuda H., Doiphode V. V., Bioorg. Med. Chem. Lett., 11, 985-989 (2001);
21. j) Matsuda H., Shimoda H., Yoshikawa M., Bioorg. Med. Chem., 9, 1031-1035 (2001);
22. k) Matsuda H., Shimoda H., Morikawa T., Yoshikawa M., Bioorg. Med. Chem. Lett., 11, 1839-1842 (2001);
23. l) Kageura T., Matsuda H., Morikawa T., Toguchida I., Harima S., Oda M., Yoshikawa M., Bioorg. Med. Chem., 9, 1887-1893 (2001).
24. Ursolic acid (7), acetylursolic acid (8), and ursonic acid (9) were identified by comparison of their methyl ester derivatives (diazomethane methylation) with reported values; Seo S., Tomita Y., Tori K., Tetrahedron Lett., 1, 7-10 (1975).
25. Kitajima J., Arai M., Tanaka Y., Chem. Pharm. Bull., 42, 608-610 (1994).
26. Maslinic acid (13, 5crategolic acid) was identified by comparison of its methyl ester derivative (diazomethane methylation) with reported values; Mallavarapu G. R., Rao S. B., Muralikrishna E., Rao G. S. R. S., Indian J. Chem., 19B, 713-714 (1980).
27. Markham K. R., Ternai B., Stanley R., Geiger H., Marby T. J., Tetrahedron, 34, 1389-1397 (1978).
28. a) Fauran F., Feniou C., Mosser J., Prat G., Eur. J. Med. Chem.-Chim. Ther., 13, 503-508 (1978);
29. b) Zapesochnaya G. G., Khim. Prir. Soedin., 6, 695-709 (1982).
30. Nonaka G., Kawahara O., Nishioka I., Chem. Pharm. Bull., 31, 3906-3914 (1983).
31. Ishimaru K., Nonaka G., Nishioka I., Phytochemistry, 26, 1147-1152 (1987).
32. β-Sitosterol and gallic acid were identified by comparison of their physical data with those of commercially obtained reagents.
33. Hara S., Okabe H., Mihashi K., Chem. Pharm. Bull., 34, 1843-1845 (1986).
34. Ohtani I., Kusumi T., Kashman Y., Kakisawa H., J. Am. Chem. Soc., 113, 4092-4096 (1991).
35. Joshi B. S., Pelletier S. W., Newton M. G., Lee D., McGaughey G. B., Puar M. S., J. Nat. Prod., 59, 759-764 (1996).
36. a) Schwartz L. B., Lewis R. A., Seldin D., Austen K. F., J. Immunol., 126, 1290-1294 (1981);
37. b) Marquardt D. L., Wasserman S. I., J. Immunol., ibid., 131, 934-939 (1983).
38. a) Yoshikawa M., Uchida E., Chatani N., Murakami N., Yamahara J., Chem. Pharm. Bull., 40, 3121-3123 (1992);
39. b) Yoshikawa M., Uchida E., Chatani N., Kobayashi H., Naitoh Y., Okuno Y., Matsuda H., Yamahara J., Murakami N., Chem. Pharm. Bull., ibid., 40, 3352-3354 (1992);
40. c) Yamahara J., Matsuda H., Shimoda H., Ishikawa H., Kawamori S., Wariishi N., Harada E., Murakami N., Yoshikawa M., Yakugaku Zasshi, 114, 401-413 (1994);
41. d) Yoshikawa M., Harada E., Naitoh Y., Inoue K., Matsuda H., Shimoda H., Yamahara J., Murakami N., Chem. Pharm. Bull., 42, 2225-2230 (1994);
42. e) Yamahara J., Matsuda H., Shimoda H., Wariishi N., Yagi N., Murakami N., Yoshikawa M., Folia Pharmacol. Jpn., 105, 365-379 (1985);
43. f) Yoshikawa M., Matsuda H., Shimoda H., Shimada H., Harada E., Naitoh Y., Miki A., Yamahara J., Murakami N., Chem. Pharm. Bull., 44, 1440-1447 (1996);
44. g) Yoshikawa M., Shimada H., Yagi N., Murakami N., Shimoda H., Yamahara J., Matsuda H., Chem. Pharm. Bull., ibid., 44, 1890-1898 (1996);
45. h) Shimoda H., Matsuda H., Yamahara J., Yoshikawa M., Biol. Pharm. Bull., 21, 809-813 (1998);
46. i) Matsuda H., Shimoda H., Yoshikawa M., Bioorg. Med. Chem., 7, 1445-1450 (1999);
47. j) Matsuda H., Shimoda H., Yamahara J., Yoshikawa M., Biol. Pharm. Bull., 22, 870-872 (1999);
48. k) Matsuda H., Shimoda H., Kageura T., Yoshikawa M., Biol. Pharm. Bull., ibid., 22, 925-931 (1999);
49. Matsuda H., Shimoda H., Uemura T., Ueda T., Yamahara J., Yoshikawa M., Chem. Pharm. Bull., 47, 1753-1758 (1999).
50. Yoshikawa M., Murakami T., Ueda T., Matsuda H., Yamahara J., Murakami N., Chem. Pharm. Bull., 44, 1736-1743 (1996).
51. Yoshikawa M., Shimada H., Shimoda H., Murakami N., Yamahara J., Matsuda H., Chem. Pharm. Bull., 44, 2086-2091 (1996).
52. Yoshikawa M., Shimada H., Horikawa S., Murakami T., Shimoda H., Yamahara J., Matsuda H., Chem. Pharm. Bull., 45, 1498-1503 (1997).
53. Kubo M., Matsuda H., Tomohiro N., Yoshikawa M., Biol. Pharm. Bull., 20, 511-516 (1997).
54. Matsuda H., Dai Y., Ido Y., Yoshikawa M., Kubo M., Biol. Pharm. Bull., 20, 1165-1170 (1997).
55. Yoshikawa M., Shimada H., Saka M., Yoshizumi S., Yamahara J., Matsuda H., Chem. Pharm. Bull., 45, 464-469 (1997).
56. Yoshikawa M., Shimada H., Komatsu H., Sakurama T., Nishida N., Yamahara J., Shimoda H., Matsuda H., Tani T., Chem. Pharm. Bull., 45, 877-882 (1997).
57. Yoshikawa M., Murakami T., Ikebata A., Wakao S., Murakami N., Matsuda H., Yamahara J., Chem. Pharm. Bull., 45, 1186-1192 (1997).
58. Yoshizumi S., Murakami T., Kadoya M., Matsuda H., Yamahara J., Yoshikawa M., Yakugaku Zasshi, 118, 118-192 (1998).
59. a) Futagami Y., Yano S., Horie S., Tsuchiya S., Ikegami F., Sekine T., Yamamoto Y., Fujimori H., Takamoto K., Watanabe K., J. Trad. Med., 13, 430-431 (1996);
60. b) Cheong H., Ryu S. Y., Oak M. H., Cheon S. H., Yoo G. S., Kim K. M., Arch. Pharm. Res., 21, 478-480 (1998).
61. Ho C., Choi E. J., Yoo G. S., Kim K. M., Ryu S. Y., Planta Med., 64, 577-578 (1998).